What is gocovri?

See the DrugPatentWatch profile for gocovri

What is Gocovri?

Gocovri is a brand-name prescription medicine that contains the active ingredient amantadine. It’s used to help treat symptoms of dyskinesia in people with Parkinson’s disease who are already taking levodopa-based therapy. It is taken as an oral medication.

How does Gocovri fit into Parkinson’s treatment?

Gocovri is aimed at reducing dyskinesia—unwanted, involuntary movements—that can occur in Parkinson’s disease as levodopa treatment continues over time. It works through the same general drug family as amantadine, which affects brain signaling related to movement.

Is Gocovri the same as amantadine?

Yes. Gocovri’s active ingredient is amantadine, but it is marketed as a specific formulation/brand for its intended use in Parkinson’s dyskinesia.

What do people usually mean when they ask for “Gocovri”?

Most people searching for “Gocovri” are trying to understand what it treats (Parkinson’s dyskinesia) and whether it’s an amantadine product, since Gocovri and amantadine are closely linked.

Sources

1. DrugPatentWatch.com – Gocovri (amantadine) information